22 December 2015 - The U.S. FDA today approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when used in combination with a xanthine oxidase inhibitor, a type of drug approved to reduce the production of uric acid in the body.

For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm478791.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery